Search clinical trials for: leuprolide

Total 355 results

Fudan University

Not yet recruiting

RWE About QOL and Compliance of Patients With OFS in China

Quality of Life | Breast Cancer | Hormone Receptor-positive Breast Cancer

China
Shanghai Ninth People's Hospital Affiliated to...

Recruiting

Exploratory Study of Molecular Profile-Associated Evidence Guided Precision Therapy for Salivary Gland Cancer（MAPS） (MAPS)

Salivary Gland Neoplasms

China
Oregon Health and Science University
Medical Research Foundation, Oregon

Completed

Relationship Between the Menstrual Cycle and Heart Disease in Women

Coronary Heart Disease

United States
Radiation Therapy Oncology Group
National Cancer Institute (NCI); NRG Oncology; Cancer and Leukemia Group B

Active, not recruiting

Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer

Prostate Cancer

United States, Canada, China, Israel
Radiation Therapy Oncology Group
National Cancer Institute (NCI); NRG Oncology

Active, not recruiting

Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer

Prostate Cancer

United States, Canada
Takeda

Completed

Leuprorelin Associated With Radiotherapy Versus Leuprorelin Alone in T3 - T4 or pT3 (on Biopsy) N0, M0 Prostate Cancer

Prostatic Neoplasms, Locally Advanced

France
PregLem SA

Completed

PGL4001 Versus GnRH-agonist in Uterine Myomas (PEARLII)

Uterine Myomas

Spain, Germany, Austria, Israel, Poland, Italy, Belgium, France, Netherlands
Southern Cross Fertility Centre
Disha Fertility and Surgical Centre,Indore,India

Unknown

Study on Influence of Leutinizing Hormone (LH) on Oocyte Maturity (LH/M2-Oocyte)

Infertility

India
Instituto de Investigación en Oncología Radioterápica...

Recruiting

Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624 (URONCOR 06-24)

Prostate Cancer | Biochemical Recurrence | Androgen Deprivation Therapy | Salvage Radiotherapy | Metastases-free Survival

Spain
Takeda

Completed

A Phase 3 Study to Evaluate the Efficacy and Safety of Relugolix (TAK-385) 40 mg Compared With Leuprorelin in the Treatment of Uterine Fibroids

Uterine Fibroids

Japan
AbbVie

Completed

Efficacy and Safety Study of Elagolix Versus Placebo or Leuprorelin Acetate in Endometriosis

Endometriosis
Takeda

Completed

A Long-term Extension Study of TAK-385 in the Treatment of Endometriosis

Endometriosis

Japan
Stanford University
National Cancer Institute (NCI)

Active, not recruiting

High-Dose Brachytherapy in Treating Patients With Prostate Cancer

Prostate Adenocarcinoma | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer

United States
M.D. Anderson Cancer Center

Not yet recruiting

Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer

Prostate Cancer

United States
University of Aarhus

Completed

Testosterone and Lipolysis, Insulin Sensitivity and Protein Metabolism

Hypogonadism

Denmark
University of California, San Francisco

Terminated

The Relation of GnRH Treatment to QTc Interval in Transgender Females

Gender Dysphoria

United States
Takeda

Completed

Efficacy and Safety of TAK-385 in the Treatment of Endometriosis

Endometriosis

Japan
SWOG Cancer Research Network
National Cancer Institute (NCI)

Active, not recruiting

S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer (e3)

Breast Cancer

United States, Puerto Rico
University of British Columbia

Unknown

Androgen Suppression Combined With Elective Nodal and Dose Escalated Radiation Therapy

Prostate Cancer

Canada
National Cancer Institute (NCI)

Terminated

Hormone Therapy and Temsirolimus in Treating Patients With Relapsed Prostate Cancer

Recurrent Prostate Cancer | Adenocarcinoma of the Prostate

United States
Lawrence Fong
Merck Sharp & Dohme LLC; Prostate Cancer Foundation; TriSalus Life Sciences,...

Active, not recruiting

Pembrolizumab +/- SD-101 in Hormone-Naïve Oligometastatic Prostate Cancer With RT and iADT

Prostatic Neoplasms

United States
Chong Kun Dang Pharmaceutical
Severance Hospital

Not yet recruiting

The Safety and Pharmacokinetic/Pharmacodynamic Study of CKD-841 in Postmenopausal Female, Phase 1

Early Puberty

Korea, Republic of
National Institute of Mental Health (NIMH)

Completed

A Treatment Study for Premenstrual Syndrome (PMS)

Menstruation Disturbances | Premenstrual Syndrome

United States
Takeda

Completed

A Study of the Effect of Enantone LP 11.25 mg (Leuprorelin) on the Histological Progression of Indolent Prostate Cancer

Prostate Cancer

France
National Institute of Allergy and Infectious Diseases...
Amgen; Sequus Pharmaceuticals

Completed

Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDS

HIV Infections | Sarcoma, Kaposi

United States
University of Michigan Rogel Cancer Center
Novartis Pharmaceuticals

Terminated

Study of Everolimus Added to Combined Hormonal and Radiation Therapy for High Risk Prostate Cancer

Prostate Cancer

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...

Completed

Bipolar Androgen-based Therapy for Prostate Cancer (BAT) (BAT)

Recurrent Prostate Cancer

United States
M.D. Anderson Cancer Center

Terminated

External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer

Prostate Cancer

United States
Institut National de la Santé Et de la Recherche...
Assistance Publique - Hôpitaux de Paris; Ministry of Health, France; Ministry...

Terminated

Comparison of Two Pharmacological Treatments of Pedophilia (PCNET)

Pedophilia

France
National Research Centre, Egypt

Completed

Role of Suppression of Endometriosis With Progestins Before IVF-ET

Endometriosis | IVF | Pregnancy Rate | Progestins | GnRH-analogue

Egypt
Pfizer
Astellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.

Completed

Study of Enzalutamide (Formerly MDV3100) as a Neoadjuvant Therapy for Patients Undergoing Prostatectomy for Localized Prostate Cancer

Prostate Cancer

Canada, United States
Fudan University

Recruiting

Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer

Prostate Cancer

China
City of Hope Medical Center
National Cancer Institute (NCI)

Active, not recruiting

Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate Cancer

Stage IV Prostate Adenocarcinoma AJCC v7 | PSA Level Greater Than Two

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Withdrawn

Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study

Biochemically Recurrent Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Oligometastatic Prostate Carcinoma

United States
Novartis Pharmaceuticals

Recruiting

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer (Adjuvant WIDER)

Early Breast Cancer

Australia
M.D. Anderson Cancer Center
Pfizer

Active, not recruiting

Sunitinib Malate With Hormonal Ablation for Patients Who Will Have Prostatectomy

Prostate Cancer

United States
Eunice Kennedy Shriver National Institute of Child...
National Institutes of Health (NIH); State University of New York - Downstate...

Unknown

Treatment of Endometriosis With Norethindrone Acetate ( NA) VS. Gonadotropin- Releasing Hormone (GnRH) Agonist (Lupron Depot 11.25 mg)

Endometriosis | Dysmenorrhea | Dyspareunia

United States
National Cancer Institute (NCI)

Completed

Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer

Prostate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer

United States, Canada
Novartis Pharmaceuticals

Completed

Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC (COMPLEEMENT-1)

Breast Cancer

United States, Belgium, Canada, Italy, Spain, United Kingdom, Austria, Czechia, Hungary, Malaysia, Saudi Arabia, Taiwan, Argentina, France, Israel, Netherlands, Russian Federation, Hong Kong, Thailand, Lebanon, Bulgaria, Denmark, Po... and more
University of Chicago
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Active, not recruiting

Metabolic Study of Women With Polycystic Ovary Syndrome and Sleep Apnea

Polycystic Ovary Syndrome | Obstructive Sleep Apnea

United States
University of California, Davis

Completed

Stereotactic Boost and Long-Term Androgen Deprivation for Adenocarcinoma of the Prostate (CCRO025)

Adenocarcinoma of the Prostate

United States
University of Colorado, Denver

Active, not recruiting

Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer

Recurrent Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer

United States
Pharmatech
Watson Pharmaceuticals; Manyak, Michael, M.D.

Terminated

Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer

Prostate Cancer

United States
The Methodist Hospital Research Institute
Celgene Corporation

Terminated

Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate Cancer

Prostatic Neoplasms

United States
M.D. Anderson Cancer Center
Novartis Pharmaceuticals

Completed

Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancer

Prostate Cancer

United States
Laboratorios Sophia S.A de C.V.

Completed

Efficacy and Safety of the Ophthalmic Solution PRO-087 Versus Systane ® Ultra and Ultra Preservative Free (087LATAMFIV) (087LATAMFIV)

Dry Eye Syndrome

Mexico
Scottish Cancer Therapy Network

Completed

Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer

Breast Cancer

United Kingdom
Rana McKay, MD
University of California, San Diego; AstraZeneca

Recruiting

Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With BRCA1/2 Gene Alterations (NePtune)

Prostate Cancer | BRCA1 Mutation | BRCA2 Mutation | Prostatic Adenocarcinoma | High-Risk Cancer

United States
Novartis Pharmaceuticals

Active, not recruiting

Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Prior Endocrine Therapy, in Patients With PIK3CA Mutant, HR+, HER2- Advanced Breast Cancer Who Have Progressed on or After Prior Treatments (BYLieve)

Breast Cancer

United States, Belgium, Italy, Spain, United Kingdom, Taiwan, Canada, Germany, Argentina, Israel, Korea, Republic of, Denmark, France, India, Chile, Netherlands, Singapore, Japan, Mexico
Seoul National University Hospital

Active, not recruiting

PersonaLized neoAdjuvant Strategy ER Positive and HER2 Negative Breast Cancer TO Increase BCS Rate

Breast Cancer

Korea, Republic of

Search clinical trials for: leuprolide

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Djibouti

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations